valsartan
Date：2021-12-03 Categories：Related Application Product
| post date: |
dec 02,2021 |
| expiry date: |
may 31,2022 |
| detailed description: |
cas no. :137862-53-4;137863-60-6;137862-87-4
|
| cas registry number: |
137862-53-4;137863-60-6;137862-87-4
|
| synonyms: |
;3-methyl-2-[pentanoyl-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]amino]-butanoic acid;n-pentanoyl-n-{[2′-(2h-tetrazol-5-yl)biphenyl-4-yl]methyl}valine;n-pentanoyl-n-{[2′-(2h-tetrazol-5-yl)biphenyl-4-yl]methyl}-l-valine;n-pentanoyl-n-{[2′-(2h-tetrazol-5-yl)biphenyl-4-yl]methyl}-d-valine;d-valine, n-(1-oxopentyl)-n-[[2′-(1h-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-;valsartan(diovan);n-(1-oxopentyl)-n-((2′-(1h-tetrazol-5-yl)(1,1′-biphenyl)-3-yl)methyl)-l-valine; |
| molecular formula: |
c24h29n5o3 |
| molecular weight: |
435.5188 |
| molecular structure: |
|
